| __timestamp | Evotec SE | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 17990000 | 91733000 |
| Thursday, January 1, 2015 | 25166000 | 87644000 |
| Friday, January 1, 2016 | 27013000 | 92365000 |
| Sunday, January 1, 2017 | 42383000 | 85656000 |
| Monday, January 1, 2018 | 57012000 | 88196000 |
| Tuesday, January 1, 2019 | 66546000 | 89971000 |
| Wednesday, January 1, 2020 | 77238000 | 93413000 |
| Friday, January 1, 2021 | 105445000 | 91355000 |
| Saturday, January 1, 2022 | 156190000 | 113676000 |
| Sunday, January 1, 2023 | 169610000 | 198366000 |
| Monday, January 1, 2024 | 218935000 |
Data in motion
In the competitive landscape of pharmaceuticals, understanding operational efficiency is crucial. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Taro Pharmaceutical Industries Ltd. and Evotec SE from 2014 to 2023. Over this period, Taro consistently outspent Evotec, with its SG&A expenses peaking at approximately 219 million in 2024, a 127% increase from 2014. In contrast, Evotec's expenses grew by 843% over the same period, reaching around 170 million in 2023. This dramatic rise highlights Evotec's aggressive expansion strategy. However, Taro's steady increase suggests a more controlled growth approach. Notably, data for Evotec in 2024 is missing, indicating potential reporting delays or strategic shifts. These insights provide a window into the financial strategies of these pharmaceutical giants, offering valuable lessons in balancing growth with operational efficiency.
Cost Management Insights: SG&A Expenses for AstraZeneca PLC and Evotec SE
SG&A Efficiency Analysis: Comparing Novartis AG and Evotec SE
Who Optimizes SG&A Costs Better? Bristol-Myers Squibb Company or Taro Pharmaceutical Industries Ltd.
Bristol-Myers Squibb Company vs Evotec SE: SG&A Expense Trends
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Evotec SE
SG&A Efficiency Analysis: Comparing Summit Therapeutics Inc. and Evotec SE
Who Optimizes SG&A Costs Better? Sarepta Therapeutics, Inc. or Evotec SE
Breaking Down SG&A Expenses: Rhythm Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
ACADIA Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Bausch Health Companies Inc. or Evotec SE: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Supernus Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.
Comparing Revenue Performance: Taro Pharmaceutical Industries Ltd. or Evotec SE?